Drug Trial Radar · NCT07832201
A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG)
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Oct 20, 2026
Primary completion
Feb 2027
Study completion Apr 2027
Sponsor
- Lead sponsor
- Sinovac Biotech Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Sep 21, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A phase IV clinical trial of Influenza Vaccine (Split Virion), Inactivated (Anflu®) developed by Sinovac Biotech Co., Ltd will be conducted in pregnant women. A total of 150 healthy pregnant women aged 18\~45 years at 22 to 34 weeks (+6 days) of pregnancy will be enrolled. All participants will be randomized to test group and control group in a ratio of 2:1 and receive one dose of vaccine (0.5 mL) of Sinovac Influenza Vaccine (Split Virion) , Inactivated (Anflu®) or Sanofi VAXIGRIP®, respectively.
Conditions
- Influenza
Interventions
Anflu®Biological
Participants will receive one dose of Sinovac Anflu® .
Vaxigrip®Biological
Participants will receive one dose of Sanofi Vaxigrip®.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The seroconversion rates (SCRs) of hemagglutination inhibition (HI) antibodies at day 28 ,as measured by HAI assay for vaccine-matched influenza A and BTime frame: 28 days after vaccination
- Incidence of adverse reactions within 28 days after vaccinationTime frame: 28 days after vaccination
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Hunan Provincial Maternal and Child Health Care Hospital
Changsha, China · Recruiting
Chengdu Women's and Children's Central Hospital
Chengdu, China · Recruiting
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China · Recruiting
Nanfang Hospital, Southern Medical University
Guangzhou, China · Recruiting
Nanjing Drum Tower Hospita
Nanjing, China · Recruiting
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.